Nephrology
Conference Coverage
Strategies for complete B-cell depletion evolve for patients with lupus nephritis
Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment...
Commentary
Transplant centers often skip the top spot on the kidney waitlist
Does this phenomenon, known colloquially as “list diving,” actually happen? This manuscript from Sumit Mohan and colleagues suggests that it does...
Conference Coverage
Lupus nephritis: Hopes, questions arise for baricitinib
Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of...
News from the FDA/CDC
FDA approves new drug, sotagliflozin, for heart failure
“It will be a reasonably tall task for sotagliflozin to come from behind and be disruptive in a space where there are already two well-established...
Conference Coverage
Early remission in lupus nephritis can still progress to advanced CKD
Patients with lupus nephritis who achieve complete remission within 1 year of starting treatment can still progress to advanced chronic kidney...
Latest News
CKD Screening in all U.S. adults found cost effective
Modeling showed screening for and treating chronic kidney disease in U.S. adults was cost effective now that SGLT2 inhibitors are available.
Conference Coverage
Biomarkers for measuring lupus nephritis treatment response gain ground
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.
News from the FDA/CDC
FDA fast tracks potential CAR T-cell therapy for lupus
The cellular therapy depletes CD19-positive B cells with the goal of ‘‘resetting’’ the immune system to achieve durable remission.
From the Journals
Experts outline comprehensive preeclampsia prevention strategy
The report recommends at-home hypertension checks, daily aspirin, surveillance, patient and provider education, long-term follow-up, and...
Latest News
SGLT2 inhibitors: Real-world data show benefits outweigh risks
“The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...
Commentary
Living kidney donors should receive money for their costs of donating
Kidney donation from living persons has become a prominent source of organs for those who need kidneys.